The World Health Organization (WHO) troubles for Shantha Biotech, the Indian vaccine unit of Sanofi Aventis seem to be on their way out.
Sanofi's global chief, Chris A Veihbacher who is in India on his annual trip speaking to CNBC-TV18 said that WHO has done the quality systems review of the manufacturing processes for its five in one vaccine shan 5. Chris A Veihbacher, chief executive officer, Sanofi Aventis,Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
